Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The 340B Prime Vendor Program is a federally mandated program managed by Apexus through a contract with the Health Resources and Services Administration (HRSA). It is designed to enhance the 340B Drug Pricing Program by negotiating significant discounts on outpatient drugs for safety-net healthcare providers. The program provides participants with access to sub-340B pricing, a diversified distribution network, and comprehensive technical assistance. Beyond procurement, it offers extensive educational resources and compliance tools to help covered entities navigate complex federal regulations. By aggregating purchasing power, the program ensures that vulnerable patient populations have improved access to affordable pharmaceutical care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 340B Prime Vendor Program.